309 related articles for article (PubMed ID: 1355262)
1. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
[TBL] [Abstract][Full Text] [Related]
2. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
3. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
Burris KD; Breeding M; Sanders-Bush E
J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
[TBL] [Abstract][Full Text] [Related]
4. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
Barker EL; Sanders-Bush E
Mol Pharmacol; 1993 Oct; 44(4):725-30. PubMed ID: 8232222
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of a 5HT1D serotonin receptor-GTP binding protein interaction in porcine and bovine brain.
Herrick-Davis K; Titeler M
Synapse; 1989; 3(4):325-30. PubMed ID: 2525822
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and molecular evidence that the contractile response to serotonin in rat stomach fundus is not mediated by activation of the 5-hydroxytryptamine1C receptor.
Baez M; Yu L; Cohen ML
Mol Pharmacol; 1990 Jul; 38(1):31-7. PubMed ID: 2196436
[TBL] [Abstract][Full Text] [Related]
8. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Sanders-Bush E; Breeding M
Psychopharmacology (Berl); 1991; 105(3):340-6. PubMed ID: 1665919
[TBL] [Abstract][Full Text] [Related]
9. Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures.
Deecher DC; Wilcox BD; Dave V; Rossman PA; Kimelberg HK
J Neurosci Res; 1993 Jun; 35(3):246-56. PubMed ID: 8394435
[TBL] [Abstract][Full Text] [Related]
10. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
Choudhary MS; Craigo S; Roth BL
Mol Pharmacol; 1993 May; 43(5):755-61. PubMed ID: 8388989
[TBL] [Abstract][Full Text] [Related]
11. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
12. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
[TBL] [Abstract][Full Text] [Related]
13. Regulation of corticotropin-releasing factor secretion from Leydig cells by serotonin.
Tinajero JC; Fabbri A; Dufau ML
Endocrinology; 1992 Apr; 130(4):1780-8. PubMed ID: 1312425
[TBL] [Abstract][Full Text] [Related]
14. Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats.
Berendsen HH; Broekkamp CL; van Delft AM
Behav Neural Biol; 1991 Mar; 55(2):214-26. PubMed ID: 1829353
[TBL] [Abstract][Full Text] [Related]
15. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
17. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
18. Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor.
Rosendorff A; Ebersole BJ; Sealfon SC
Brain Res Mol Brain Res; 2000 Dec; 84(1-2):90-6. PubMed ID: 11113535
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor.
Herrick-Davis K; Grinde E; Gauthier C; Teitler M
Ann N Y Acad Sci; 1998 Dec; 861():140-5. PubMed ID: 9928251
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
McKenna DJ; Peroutka SJ
J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
